Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening

Aliota, 2017, Zika in the Americas, year 2: what have we learned? what gaps remain? a report from the global virus network, Antivir. Res., 144, 223, 10.1016/j.antiviral.2017.06.001

Annamalai, 2017, Zika virus encoding non-glycosylated envelope protein is attenuated and defective in neuroinvasion, J. Virol., 91, 10.1128/JVI.01348-17

Avelino-Silva, 2016, Association between Guillain-Barre syndrome and zika virus infection, Lancet, 387, 2599, 10.1016/S0140-6736(16)30843-1

Baronti, 2014, Complete coding sequence of zika virus from a French Polynesia outbreak in 2013, Genome Announc., 2, 10.1128/genomeA.00500-14

Barrows, 2016, A screen of FDA-approved drugs for inhibitors of zika virus infection, Cell Host Microbe, 20, 259, 10.1016/j.chom.2016.07.004

Butcher, 2001, A mechanism for initiating RNA-dependent RNA polymerization, Nature, 410, 235, 10.1038/35065653

Carteaux, 2016, Zika virus associated with meningoencephalitis, N. Engl. J. Med., 374, 1595, 10.1056/NEJMc1602964

Cauchemez, 2016, Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study, Lancet, 387, 2125, 10.1016/S0140-6736(16)00651-6

Chan, 2016, Zika fever and congenital Zika syndrome: an unexpected emerging arboviral disease, J. Infect., 72, 507, 10.1016/j.jinf.2016.02.011

Che, 2009, The development, optimization and validation of an assay for high throughput antiviral drug screening against dengue virus, Int. J. Clin. Exp. Med., 2, 363

Choi, 2009, RNA-dependent RNA polymerases from flaviviridae, Curr. Opin. Struct. Biol., 19, 746, 10.1016/j.sbi.2009.10.015

Coutard, 2017, Zika virus methyltransferase: structure and functions for drug design perspectives, J. Virol., 91, e02202, 10.1128/JVI.02202-16

Coyne, 2016, Zika virus - reigniting the TORCH, Nat. Rev. Microbiol., 14, 707, 10.1038/nrmicro.2016.125

Cugola, 2016, The Brazilian Zika virus strain causes birth defects in experimental models, Nature, 534, 267, 10.1038/nature18296

Deseda, 2017, Epidemiology of zika, Curr. Opin. Pediatr., 29, 97, 10.1097/MOP.0000000000000442

Diamond, 2002, Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA, Virology, 304, 211, 10.1006/viro.2002.1685

Dick, 1952, Zika virus. I. Isolations and serological specificity, Trans. Roy. Soc. Trop. Med. Hyg., 46, 509, 10.1016/0035-9203(52)90042-4

Duan, 2017, The crystal structure of Zika virus NS5 reveals conserved drug targets, EMBO J., 36, 919, 10.15252/embj.201696241

Fauci, 2016, Zika virus in the americas–yet another arbovirus threat, N. Engl. J. Med., 374, 601, 10.1056/NEJMp1600297

Godoy, 2017, Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase, Nat. Commun., 8, 14764, 10.1038/ncomms14764

Gulland, 2016, Zika virus is a global public health emergency, declares WHO, BMJ, 352, i657, 10.1136/bmj.i657

Julander, 2017, Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model, Antivir. Res., 137, 14, 10.1016/j.antiviral.2016.11.003

Larocca, 2016, Vaccine protection against Zika virus from Brazil, Nature, 536, 474, 10.1038/nature18952

Lazear, 2016, Zika virus: new clinical syndromes and its emergence in the Western hemisphere, J. Virol., 90, 4864, 10.1128/JVI.00252-16

Lazear, 2016, A mouse model of zika virus pathogenesis, Cell Host Microbe, 19, 720, 10.1016/j.chom.2016.03.010

Lim, 2016, Potent allosteric dengue virus NS5 polymerase inhibitors: mechanism of action and resistance profiling, PLoS Pathog., 12, 10.1371/journal.ppat.1005737

Lim, 2015, The dengue virus NS5 protein as a target for drug discovery, Antivir. Res., 119, 57, 10.1016/j.antiviral.2015.04.010

Lu, 2013, Crystal Structure of the full-length Japanese encephalitis virus NS5 reveals a conserved methyltransferase-polymerase interface, PLoS Pathog., 9, 10.1371/journal.ppat.1003549

Malet, 2008, The flavivirus polymerase as a target for drug discovery, Antivir. Res., 80, 23, 10.1016/j.antiviral.2008.06.007

Mastrangelo, 2012, Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug, J. Antimicrob. Chemother., 67, 1884, 10.1093/jac/dks147

Mecharles, 2016, Acute myelitis due to Zika virus infection, Lancet, 387, 1481, 10.1016/S0140-6736(16)00644-9

Miner, 2017, Zika virus pathogenesis and tissue tropism, Cell Host Microbe, 21, 134, 10.1016/j.chom.2017.01.004

Mlakar, 2016, Zika virus associated with microcephaly, N. Engl. J. Med., 374, 951, 10.1056/NEJMoa1600651

Munoz, 2016, Zika virus-associated neurological disease in the adult: Guillain-Barre syndrome, encephalitis, and myelitis, Semin. Reprod. Med., 34, 273, 10.1055/s-0036-1592066

Nascimento, 2017, Zika virus infection-associated acute transient polyneuritis, Neurology, 88, 2330, 10.1212/WNL.0000000000004026

Ng, 2008, Structure-function relationships among RNA-dependent RNA polymerases, Curr. Top. Microbiol. Immunol., 320, 137

Omura, 2017, Ivermectin and malaria control, Malar. J., 16, 172, 10.1186/s12936-017-1825-9

Parra, 2016, Guillain-barre syndrome associated with zika virus infection in Colombia, N. Engl. J. Med., 375, 1513, 10.1056/NEJMoa1605564

Perera, 2008, Structural proteomics of dengue virus, Curr. Opin. Microbiol., 11, 369, 10.1016/j.mib.2008.06.004

Ramharack, 2017, Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery, J. Biomol. Struct. Dynam., 1, 10.1080/07391102.2017.1313175

Rather, 2017, Prevention and control strategies to counter ZIKA epidemic, Front. Microbiol., 8, 305, 10.3389/fmicb.2017.00305

Roos, 2016, Zika virus-a public health emergency of international concern, J. Neurol., 73, 1395

Rossi, 2016, Characterization of a novel murine model to study zika virus, Am. J. Trop. Med. Hyg., 94, 1362, 10.4269/ajtmh.16-0111

Salam, 2017, Clinical trials of therapeutics for the prevention of congenital zika virus disease: challenges and potential solutions, Ann. Intern. Med., 166, 725, 10.7326/M16-2530

Shan, 2016, Zika virus: diagnosis, therapeutics, and vaccine, Adv. Infect. Dis., 2, 170, 10.1021/acsinfecdis.6b00030

Shi, 2017, Structural biology of the zika virus, Trends Biochem. Sci., 42, 443, 10.1016/j.tibs.2017.02.009

Upadhyay, 2017, Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5, Acta Crystallogr. F Struct. Biol. Commun., 73, 116, 10.1107/S2053230X17001601

Wang, 2017, The structure of Zika virus NS5 reveals a conserved domain conformation, Nat. Commun., 8, 14763, 10.1038/ncomms14763

Weaver, 2016, Zika virus: history, emergence, biology, and prospects for control, Antivir. Res., 130, 69, 10.1016/j.antiviral.2016.03.010

Webb, 2014, Protein structure modeling with MODELLER, Meth. Mol. Biol., 1137, 1, 10.1007/978-1-4939-0366-5_1

Yap, 2007, Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution, J. Virol., 81, 4753, 10.1128/JVI.02283-06

Yu, 2017, Effective suckling C57BL/6, Kunming, and BALB/c mouse models with remarkable neurological manifestation for zika virus infection, Viruses, 9, e165, 10.3390/v9070165

Yuan, 2016, Recapitulating cross-species transmission of simian immunodeficiency virus SIVcpz to humans by using humanized BLT mice, J. Virol., 90, 7728, 10.1128/JVI.00860-16

Zhao, 2017, Structure and function of the Zika virus full-length NS5 protein, Nat. Commun., 8, 14762, 10.1038/ncomms14762

Zmurko, 2016, The viral polymerase inhibitor 7-deaza-2'-C-methyladenosine is a potent inhibitor of in vitro zika virus replication and delays disease progression in a robust mouse infection model, PLoS Neglected Trop. Dis., 10, 10.1371/journal.pntd.0004695